Insights

Early-stage Growth Ictero Medical is a small, seed-to-early-stage medical device company developing a novel cryoablation system for gallstone disease, backed by a $6M Series A in 2022 and total funding of $15M, signaling readiness to scale and seek strategic partnerships.

Strategic Investors Recent funding rounds included MedTex Ventures and S3 Ventures with an undisclosed strategic investor, indicating interest from specialized and strategic backers who could facilitate large-scale manufacturing partnerships, distribution deals, and hospital system adoption.

Clinical Focus Product targets high‑risk gallstone patients via a minimally invasive cryoablation approach, presenting opportunities to connect with gastroenterology and interventional radiology departments, as well as hospital procurement focused on high‑risk patient care improvements.

Partnership Potential Past collaboration with Texas Medical Center and emphasis on advanced device technology suggests open avenues for joint development, pilot programs, and access to clinical networks for trials and early‑adopter sites.

Growth Readiness Small team size and cloud‑based tech stack indicate an opportunity to offer scalable manufacturing, regulatory support, and commercialization services (e.g., pilot manufacturing, quality systems, and field service) to accelerate time‑to‑market and reimbursement milestones.

Similar companies to Ictero Medical

Ictero Medical Tech Stack

Ictero Medical uses 8 technology products and services including cdnjs, WordPress, MySQL, and more. Explore Ictero Medical's tech stack below.

  • cdnjs
    Content Delivery Network
  • Content Management System
  • MySQL
    Database
  • Google Fonts API
    Font Scripts
  • Infrastructure As A Service
  • Platform As A Service
  • Contact Form 7
    Web Platform Extensions

Media & News

Ictero Medical's Email Address Formats

Ictero Medical uses at least 1 email format:
Ictero Medical Email FormatsExamplePercentage
First.Last@icteromedical.comJohn.Doe@icteromedical.com
100%

Frequently Asked Questions

What is Ictero Medical's official website and social media links?

Minus sign iconPlus sign icon
Ictero Medical's official website is icteromedical.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Ictero Medical generate?

Minus sign iconPlus sign icon
As of September 2026, Ictero Medical's annual revenue is estimated to be <$1M.

What is Ictero Medical's NAICS code?

Minus sign iconPlus sign icon
Ictero Medical's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Ictero Medical have currently?

Minus sign iconPlus sign icon
As of September 2026, Ictero Medical has approximately 2 employees across 1 continents, including North America. Key team members include Board Observer: J. S. Explore Ictero Medical's employee directory with LeadIQ.

What industry does Ictero Medical belong to?

Minus sign iconPlus sign icon
Ictero Medical operates in the Medical Equipment Manufacturing industry.

What technology does Ictero Medical use?

Minus sign iconPlus sign icon
Ictero Medical's tech stack includes cdnjs, WordPress, MySQL, Google Workspace, Google Fonts API, Google Cloud, WP Engine and Contact Form 7.

What is Ictero Medical's email format?

Minus sign iconPlus sign icon
Ictero Medical's email format typically follows the pattern of First.Last@icteromedical.com. Find more Ictero Medical email formats with LeadIQ.

How much funding has Ictero Medical raised to date?

Minus sign iconPlus sign icon
As of September 2026, Ictero Medical has raised $15M in funding. The last funding round occurred on Apr 29, 2022 for $2.5M.

When was Ictero Medical founded?

Minus sign iconPlus sign icon
Ictero Medical was founded in 2018.
Ictero Medical logo

Ictero Medical

Medical Equipment ManufacturingTexas, United States2-10 Employees

Ictero Medical is a medical equipment company based in Houston, Texas, developing a minimally invasive cryoablation system intended to treat gallstone disease in high-risk patients. The firm's work focuses on providing a catheter-based approach aimed at reducing procedural risk and enabling treatment for individuals who may not tolerate more invasive options. Positioned within the medical device sector, Ictero Medical emphasizes devices designed to address gallbladder disease and related conditions, seeking to expand options for a patient population with limited alternatives. The company operates on a small team and has engaged with industry partners and medical centers to advance its technology, with recent activity indicating progress in bringing its minimally invasive solution closer to clinical use. } }\n} } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } }

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2018
Employees
2-10

Section iconFunding & Financials

  • $15M

    Ictero Medical has raised a total of $15M of funding over 8 rounds. Their latest funding round was raised on Apr 29, 2022 in the amount of $2.5M as a Series A.

  • <$1M

    Ictero Medical's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.